As of 2024-12-13, the Intrinsic Value of Immunodiagnostic Systems Holdings PLC (IDH.L) is
219.01 GBP. This IDH.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 378.00 GBP, the upside of Immunodiagnostic Systems Holdings PLC is
-42.10%.
The range of the Intrinsic Value is 182.56 - 305.18 GBP
219.01 GBP
Intrinsic Value
IDH.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
182.56 - 305.18 |
219.01 |
-42.1% |
| DCF (Growth 10y) |
191.41 - 309.11 |
226.77 |
-40.0% |
| DCF (EBITDA 5y) |
276.31 - 391.65 |
327.37 |
-13.4% |
| DCF (EBITDA 10y) |
269.34 - 396.43 |
323.68 |
-14.4% |
| Fair Value |
13.57 - 13.57 |
13.57 |
-96.41% |
| P/E |
87.89 - 271.65 |
164.47 |
-56.5% |
| EV/EBITDA |
335.42 - 703.99 |
490.32 |
29.7% |
| EPV |
120.06 - 140.52 |
130.29 |
-65.5% |
| DDM - Stable |
44.56 - 136.83 |
90.70 |
-76.0% |
| DDM - Multi |
117.77 - 270.99 |
163.07 |
-56.9% |
IDH.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
108.80 |
| Beta |
0.93 |
| Outstanding shares (mil) |
0.29 |
| Enterprise Value (mil) |
88.32 |
| Market risk premium |
5.34% |
| Cost of Equity |
7.80% |
| Cost of Debt |
7.92% |
| WACC |
7.76% |